Booth™ by Opio™: Developing technology to expand the reach of opioid treatment programs into rural and underserved areas.

该项目的目标是开发一种治疗亭，其技术允许阿片类药物治疗计划 在医学观察下通过远程医疗远程分配美沙酮或丁丙诺啡 治疗室里的一位病人。我们相信，机器人自动化是执行同样任务的理想应用 护士在给药窗口的机械功能。具体地说，这些机械功能包括瓶 为病人定位、封口、贴标签和放置。这将允许护士使用他们的临床技能， 为广大地理区域的患者提供服务，并且只使用机器人来实际配药 直接给一个病人。技术和自动化将为阿片类药物创造一个弹性和灵活的商业模式 治疗计划(OTP)，提供非接触式患者-护士体验和集中给药队列 这允许诊所在OTP诊所之间分担剂量窗口工作量。美国药品监督管理局 (DEA)管理OTP的活动和药物储存。这就是为什么我们的第一个也是最关键的里程碑是 设计、制造和符合性测试满足我们的技术需求和21 CFR的定制保险箱 §1301.72。为了确定我们的技术需求，我们必须完成以下功能需求规范 硬件。在DEA批准后，我们将开发软件体系结构和设计，并制作原型 端到端的机器人过程，从泵入瓶子、盖上盖子、贴标签并将瓶子放入指定的 地点。之后，完成了丁丙诺啡分配器的工程设计、样机、软件设计 阿尔法装置的开发和组装将完成。这个项目的愿景是成为 催化剂使OTP能够通过非接触式、高效的 经验，提供一种安全可靠的方法，通过远程医疗进行美沙酮诱导，并允许OTP 通过卫星医疗室将服务扩展到农村和服务不足的地区。

The goal of this project is to develop a treatment booth with technology that allows opioid treatment programs to remotely dispense, either methadone or buprenorphine, under medical observation through telemedicine to a patient in a treatment booth. We believe that robotic automation is the ideal application to perform the same mechanical functions of the nurse at the dosing window. Specifically, these mechanical functions include bottle positioning, capping, labeling, and placing for patient. This would allow nurses to use their clinical skills, serving patients across vast geographic regions, and only using a robot to physically dispense the medication directly to a patient. Technology and automation will create a resilient and agile business model for opioid treatment programs (OTPs), allowing a contactless patient-nurse experience and a centralized dosing queue which allows clinics to share the dosing window workload across OTP clinics. The Drug Enforcement Agency (DEA) regulates activities and medication storage at OTPs. That is why our first, and most critical, milestone is to design, build, and compliance test a custom safe that meets our technical needs as well as 21 CFR §1301.72. To determine our technical needs, we must complete the functional requirement specifications for the hardware. After DEA approval, we will develop the software architecture and design, and prototype the end-to-end robotic process from pumping into a bottle, capping, labeling, and placing bottle in a specified location. After that, the complete design engineering, buprenorphine dispenser prototype, software development and the assembly of the alpha device will be completed. The vision of this project is to be the catalyst that allows OTPs to provide uninterrupted service to patients through a contactless and efficient experience, provide a safe and secure method for methadone inductions via telemedicine, and to allow OTPs expand services to rural and underserved areas through satellite medication units.